US Congress told use of BPA in formula cans safe
New York based company Bristol-Myers Squibb spent $840,000 (€614,040) in the third quarter on lobbying the US Congress on safety and pricing issues including a bill that would ban the use of Bisphenol A (BPA) in infant formula food packaging, according...